R A Forse, R Leibel, J Askanazi, J Hirsch, J M Kinney
Index: Ann. Surg. 206(6) , 744-51, (1987)
Full Text: HTML
Adipocyte lipolysis and its adrenergic control were studied in vitro from normal patients and those with trauma and sepsis. The adrenergic receptors were studied in terms of their responsiveness, a measure of the postreceptor mechanism, and their sensitivity, a measure of the receptor number or affinity. With early trauma, beta-adrenergic responsiveness and receptor number were significantly decreased. This is desensitization of the beta-receptors with down regulation and indicates increased in vivo lipolysis in early injury. After 4 days these changes had returned to normal. Early sepsis resulted in a significant increase in beta- and alpha-receptor responsiveness with beta-upregulation. This indicated hypersensitivity of the adipocyte adrenergic receptors and suggests the presence of an in vivo block of the adrenergic receptors in early sepsis. This would decrease adipocyte lipolysis. After 4 days there was a decrease in beta-receptor responsiveness in the patients with sepsis, indicating that the adrenergic receptor block was no longer present and adipocyte adrenergic stimulated lipolysis was increased.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
(-)-Isoproterenol tartrate
CAS:54750-10-6 |
C15H23NO9 |
Beta-adrenergic receptor activation facilitates induction of...
2005-03-30 [J. Neurosci. 25(13) , 3294-303, (2005)] |
Effects of noradrenaline on frequency tuning of rat auditory...
1997-04-01 [Eur. J. Neurosci. 9(4) , 833-47, (1997)] |
[Effect of synaptically active substances on the hyperthermi...
1981-03-01 [Biull. Eksp. Biol. Med. 91(3) , 304-5, (1981)] |
Nasal polyposis: immunohistochemistry and bioelectrical find...
1997-02-01 [J. Allergy Clin. Immunol. 99(2) , 165-75, (1997)] |
The use of indentometry to study the effect of agents known ...
1985-03-15 [Experientia 41(3) , 378-9, (1985)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved